Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-16,115
Closed -$1.58M 2704
2025
Q2
$1.58M Buy
+16,115
New +$1.52M ﹤0.01% 1581
2024
Q3
Sell
-61,391
Closed -$5.65M 2980
2024
Q2
$5.65M Sell
61,391
-29,836
-33% -$2.77M ﹤0.01% 1027
2024
Q1
$8.41M Sell
91,227
-19,352
-18% -$1.81M 0.01% 939
2023
Q4
$10.5M Buy
110,579
+100
+0.1% +$9.34K 0.01% 877
2023
Q3
$10.3M Buy
110,479
+71,705
+185% +$6.63M 0.01% 818
2023
Q2
$3.54M Buy
38,774
+31,868
+461% +$2.61M ﹤0.01% 1200
2023
Q1
$509K Sell
6,906
-8,652
-56% -$749K ﹤0.01% 2033
2022
Q4
$1.29M Buy
15,558
+3,193
+26% +$288K ﹤0.01% 1855
2022
Q3
$1.24M Sell
12,365
-7,778
-39% -$927K ﹤0.01% 1741
2022
Q2
$2.14M Buy
20,143
+6,346
+46% +$811K ﹤0.01% 1555
2022
Q1
$2.39M Buy
13,797
+3,999
+41% +$597K ﹤0.01% 1526
2021
Q4
$1.6M Sell
9,798
-4,800
-33% -$771K ﹤0.01% 1790
2021
Q3
$2.19M Buy
14,598
+10,855
+290% +$2.26M ﹤0.01% 1495
2021
Q2
$913K Buy
3,743
+2,163
+137% +$568K ﹤0.01% 1815
2021
Q1
$420K Sell
1,580
-939
-37% -$265K ﹤0.01% 2095
2020
Q4
$731K Buy
2,519
+1,060
+73% +$272K ﹤0.01% 1924
2020
Q3
$347K Buy
+1,459
New +$332K ﹤0.01% 2164
2020
Q2
Sell
-3,644
Closed -$668K 2642
2020
Q1
$668K Sell
3,644
-533
-13% -$94.8K ﹤0.01% 1637
2019
Q4
$699K Sell
4,177
-106
-2% -$15.8K ﹤0.01% 2037
2019
Q3
$560K Sell
4,283
-10,659
-71% -$1.39M ﹤0.01% 2269
2019
Q2
$1.81M Sell
14,942
-11,937
-44% -$1.42M ﹤0.01% 1557
2019
Q1
$3.31M Buy
26,879
+9,252
+52% +$1.16M 0.01% 1282
2018
Q4
$2.06M Buy
17,627
+15,831
+881% +$1.87M ﹤0.01% 1485
2018
Q3
$224K Buy
+1,796
New +$198K ﹤0.01% 2371
2017
Q1
Sell
-6,810
Closed -$290K 2128
2016
Q4
$290K Buy
+6,810
New +$290K ﹤0.01% 2259

Other funds holding AMED

HSBC Holdings's AMED Position: Q3 2025 in Review

HSBC Holdings sold out of Amedisys (AMED) in Q3 2025, closing a stake of 16,115 shares — an estimated $1.58M sold.

HSBC Holdings first reported a position in AMED in Q4 2016 and held it in 25 quarters. The position peaked at $10.5M in Q4 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • HSBC Holdings reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • HSBC Holdings sold 16,115 Amedisys shares in Q3 2025, an estimated $1.58M.
  • HSBC Holdings first reported a position in Amedisys in Q4 2016 and held it in 25 quarters.
  • HSBC Holdings's Amedisys position peaked at $10.5M in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on HSBC Holdings's 13F filing for Q3 2025, filed 13 Nov 2025.